- Home
- QNTM vs DSS Comparison
QNTM vs DSS Comparison
Compare QNTM & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNTM
- DSS
- Stock Information
- Founded
- QNTM 1998
- DSS 1984
- Country
- QNTM Canada
- DSS United States
- Employees
- QNTM N/A
- DSS N/A
- Industry
- QNTM
- DSS Containers/Packaging
- Sector
- QNTM
- DSS Consumer Discretionary
- Exchange
- QNTM NYSE
- DSS Nasdaq
- Market Cap
- QNTM 8.7M
- DSS 7.3M
- IPO Year
- QNTM N/A
- DSS N/A
- Fundamental
- Price
- QNTM $8.04
- DSS $0.93
- Analyst Decision
- QNTM
- DSS
- Analyst Count
- QNTM 0
- DSS 0
- Target Price
- QNTM N/A
- DSS N/A
- AVG Volume (30 Days)
- QNTM 1.5M
- DSS 83.2K
- Earning Date
- QNTM 05-13-2025
- DSS 03-31-2025
- Dividend Yield
- QNTM N/A
- DSS N/A
- EPS Growth
- QNTM N/A
- DSS N/A
- EPS
- QNTM N/A
- DSS N/A
- Revenue
- QNTM N/A
- DSS $19,097,000.00
- Revenue This Year
- QNTM N/A
- DSS N/A
- Revenue Next Year
- QNTM N/A
- DSS N/A
- P/E Ratio
- QNTM N/A
- DSS N/A
- Revenue Growth
- QNTM N/A
- DSS N/A
- 52 Week Low
- QNTM $2.70
- DSS $0.77
- 52 Week High
- QNTM $44.72
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- QNTM 60.11
- DSS 51.43
- Support Level
- QNTM $6.45
- DSS $0.78
- Resistance Level
- QNTM $12.45
- DSS $1.03
- Average True Range (ATR)
- QNTM 1.66
- DSS 0.11
- MACD
- QNTM 0.28
- DSS -0.00
- Stochastic Oscillator
- QNTM 43.80
- DSS 46.16
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.